LILRB2

LILRB2

LILRB2 Overview

Molecule Name
Leukocyte immunoglobulin-like receptor subfamily B member 2
Synonyms
LILRB2,ILT4,LIR2,MIR10,CD85d
Drug Development Progress
Drugs in Clinical Trials11
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Leukocyte immunoglobulin-like receptor 2,CD85 antigen-like family member D,Immunoglobulin-like transcript 4,ILT-4,Monocyte/macrophage immunoglobulin-like receptor 10,MIR-10,CD_antigen: CD85d,LILRB2,Leukocyte Immunoglobulin Like Receptor B2,Leucocyte Ig-Like Receptor B2,MIR10,Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 2,Ig-Like Transcript 4,Myeloid Inhibitory Receptor 10,CD85d Antigen,ILT4,LIR2,CD85d,LIR-2,LIRB2
Background
Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

LILRB2 Product List

Species
  • Human(4)
  • Cynomolgus(2)
Tag
  • His Tag(2)
  • His Tag & Avi Tag(2)
  • Fc Tag(1)
  • Fc Tag & Avi Tag(1)
Host
  • HEK293(6)
Conjugate
  • Biotin-labeled(3)
  • Unconjugated(3)
Grade
  • RUO(6)
Low Endotoxin
  • Yes(1)
  • No(5)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
LILRB2
HOTAvitag
LI2-H82E7
Biotinylated Human LILRB2 / CD85d / ILT4 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$380.00

25ug
LILRB2
Human LILRB2 / CD85d / ILT4 Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$310.00

100ug
LILRB2
HOTAvitag
LI2-H82F5
Biotinylated Human LILRB2 / CD85d / ILT4 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$380.00

25ug
LILRB2
Human LILRB2 / CD85d / ILT4 Protein, Fc Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$310.00

100ug
LILRB2
Cynomolgus LILRB2 / CD85d / ILT4 Protein, His Tag
Cynomolgus
HEK293
SDS-PAGE

$270.00

100ug
LILRB2
Avitag
LI2-C82E3
Biotinylated Cynomolgus LILRB2 / CD85d / ILT4 Protein, His,Avitag™
Cynomolgus
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
LILRB2 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
Project Name
LILRB2 mAb - 01
Project Stage
PCC
Molecule Type
Monoclonal
Molecule Source
Humanized Mouse
Disease Area
Solid Tumor
Indication
Solid tumor
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
PolzastobartJTX-8064Phase 2 ClinicalJounce Therapeutics Inc
Neoplasms
Details
IO-108IO-108Phase 2 ClinicalYiming Biomedical Technology (Hangzhou) Co Ltd
Liver Neoplasms; Solid tumours
Details
MK-4830MK-4830Phase 2 ClinicalAgenus Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Ovarian Neoplasms; Solid tumours
Details
SPX-303SPX-303Phase 2 ClinicalSparX Biopharmaceutical Corp
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
Details
OR-502OR502; OR-502Phase 2 ClinicalOncoResponse Inc
Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms; Skin Melanoma; Solid tumours
Details
NGM-707NGM-707Phase 2 ClinicalMerck & Co, NGM Biopharmaceuticals Inc
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Glioblastoma; Melanoma; Mesothelioma; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uterine Cervical Neoplasms
Details
AK-150 (Akeso)AK150; AK-150Phase 1 Clinical
Solid tumours
Details
CHS-1000CHS-1000Phase 1 ClinicalCoherus Biosciences Inc
Solid tumours
Details
BMS-986406BMS-986406; ONO-7226Phase 1 ClinicalBristol-Myers Squibb Company
Neoplasms
Details
CDX-585CDX-585; BSI-585Phase 1 ClinicalBiosion Inc, Celldex Therapeutics
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Solid tumours; Stomach Neoplasms
Details
ES-009ES-009Phase 1 ClinicalElpiscience (Shanghai) Biopharma Ltd
Neoplasms; Solid tumours
Details
Customer Reviews